Propensity Score Weighting
Propensity Score Weighting - Related Videos
06:55
Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
0 Views •
Cited by 15 •
2020
When randomized controlled trials are not feasible, a comprehensive health care data source like the Military Health System Data Repository provides an attractive alternative for retrospective analyses. Incorporating mortality data from the national death index and balancing differences between groups using propensity weighting helps reduce biases inherent in retrospective designs.
01:30
Marginal Propensity to Consume
0 Views •
2025
The marginal propensity to consume (MPC) describes how much of an additional dollar of disposable income a household is likely to spend rather than save. It provides insight into consumer behavior and is a foundational component in the analysis of fiscal policy effectiveness and national income determination.Concept and MeasurementMPC is measured as the ratio of the change in consumption (ΔC) to the change in disposable income (ΔY), expressed as:MPC = ΔC / ΔYFor example, if an individual's...
06:57
Semi-Automatic Graphical Tool for Measuring Coronary Artery Spatially Weighted Calcium Score from Gated Cardiac Computed Tomography Images
0 Views •
Cited by 1 •
2023
This video demonstrates the use of a novel graphical tool for measuring the spatially weighted calcium score (SWCS), an alternative to the Agatston score, for quantifying coronary artery calcification. The graphical tool computes SWCS based on image data from gated cardiac computed tomography and user-defined paths of the coronary arteries.
06:45
Transmembrane Domain Oligomerization Propensity determined by ToxR Assay
0 Views •
Cited by 7 •
2011
An efficient procedure to assess the oligomerization propensity of single-pass transmembrane domains (TMDs) is described. Chimeric proteins consisting of the TMD fused to ToxR are expressed in an E. coli reporter strain. TMD-induced oligomerization causes dimerization of ToxR, activation of transcription and production of the reporter protein, -galactosidase.
01:26
The Marginal Propensity to Save
0 Views •
2025
The Marginal Propensity to Save (MPS) describes the proportion of additional disposable income that a household saves rather than spends. It is calculated by dividing the change in savings by the change in disposable income. This ratio helps economists understand individual and aggregate saving behavior and is critical in developing models of income distribution and economic growth.Example of MPS CalculationTo illustrate, imagine that Kevin's disposable income increases by one hundred dollars.
FAQs
Inverse-probability weights give greater influence to patients whose observed treatment assignment was less expected from their measured characteristics. This reshapes the original observational data into a weighted pseudo-population where baseline characteristics are more comparable between treatment groups. The resulting comparison is intended to reduce confounding from those measured characteristics when estimating treatment effects or risks.
The treatment model determines each patient’s estimated probability of receiving the treatment based on recorded covariates. If the model is poorly specified, those probabilities may not adequately represent treatment-selection differences, weakening the balance created by weighting. Careful inclusion and measurement of relevant characteristics therefore directly affect how credible the weighted comparison is.
Limited overlap occurs when patients in one treatment group have characteristics associated with treatment probabilities rarely seen in the other group. In that situation, weighting has less empirical information for making a comparable contrast, and estimates may become less reliable. Researchers should evaluate whether the treatment groups share sufficient measured characteristics before interpreting causal results.
A typical workflow identifies relevant baseline covariates, estimates each patient’s probability of receiving the observed treatment, and applies inverse-probability weights to construct the pseudo-population. Researchers then compare outcomes across the weighted treatment groups and interpret the estimates in light of covariate measurement, treatment-model specification, and overlap between groups.
The method is useful when randomized treatment assignment is unavailable and investigators need to compare treatments using observational patient data. It supports comparative-effectiveness research and real-world evidence by addressing differences in measured baseline characteristics, such as age, disease severity, and comorbidities. Its role is to make treatment comparisons more informative, not to replace sound study design.
After weighting creates more comparable treatment groups, investigators can estimate average treatment effects, treatment risks, or other outcome contrasts supported by the study data. These results describe differences under the weighted comparison and depend on the quality of measured covariates and the treatment model. Interpretation should therefore distinguish adjustment for observed factors from broader causal certainty.